At a recent event organized by that consortium, the New Jersey Alliance for Clinical and Translational Science(NJACTS), leaders from academia, healthcare, government and the pharmaceutical industry discussed the future of scientific and clinical trial innovation in the state. These new innovations will result from a $33-million grant from the National Institutes of Health (NIH). To read the full story.
Recent Posts
- New NJACTS Publication
- Scientists Find Why Ozempic Changes the Types of Food People Eat.
- Rutgers Physician Assistant Studies is Third in U.S. News and World Report’s Graduate School Rankings.
- Autism Rates Hit Record High, With One in 31 Children Affected, CDC Reports.
- How Much Do You Need to Walk to Offset the Harmful Effects of Sitting? Experts Explain.
Categories
- Community (2,261)
- Covid (986)
- CTO Events (6)
- News (2,881)
- Pilots (21)